|
A cash capital increase with pre-emptive rights, in the gross amount of EUR 1,192 millions, was established by means of officially recorded instruments dated 2 and 4 July 2007. Following that operation, GBL's capital of 161,358,287 shares and the share premiums amounted to EUR 653.1 million and EUR 3,825.3 million respectively.
GBL announced in late March 2006 and launched in early April a capital increase open to shareholders, in keeping with pre-emptive rights, in the proportion of one new share for 15 existing shares at the price of EUR 80. The share issue was well received, with a participation rate of 95.2% of existing shareholders. The remainder was subscribed by new investors via scripts. The operation involved the issue of 8.8 million shares for an amount of EUR 709.4 million.
In March 2005, GBL has issued exchangeable bonds due 2012 for an aggregate amount of EUR 435 million intented for foreign institutional investors. The latter are exchangeable for 5,000,000 GBL shares.
On 26 April 2001, the Extraordinary General Meetings of shareholders of Groupe Bruxelles Lambert S.A. and of Electrafina, its 82.8% subsidiary, approved the merger of the two companies. The operation was conducted in accordance with the conditions set out in the merger proposal filed at the Registry of the Commercial Court of Brussels on 14 March 2001. The parity was fixed, after dividing the Electrafina share by 3, to 5 new Electrafina shares for 1 Groupe Bruxelles Lambert S.A. share. The merged company is called Groupe Bruxelles Lambert, in abbreviated form GBL.
This merger, called for by the financial community and shareholders alike, will further simplify the group’s organisation chart and add to its clarity and transparency. |